InvestorsHub Logo
Followers 6
Posts 130
Boards Moderated 0
Alias Born 01/25/2014

Re: pijoe post# 10589

Thursday, 07/24/2014 2:00:51 PM

Thursday, July 24, 2014 2:00:51 PM

Post# of 106837
Very well done, pijoe. I believe you've formed a very cogent analysis of something that has been discussed here generally, for some time...and specifically as of late. If a business, or company, stands to benefit or profit from a successful enterprise, then it's just common sense to know another will not. That is why competition evolves using various methods to alter the course of that business. After a launch of a viable product or service this is mostly done in the field...before marketing, it is done in places like here...in the arena of ideas. There are, I believe, obvious and coordinated efforts to alter the course of Bioheart....it is and has been obvious to all for some time now. If Bioheart succeeds, other companies will have failed to be the first to an untapped and unlimited market...one that has the attention of academia and large pharmaceutical and device companies. I know this to be true...and so I am not the least bit persuaded by the constant drumbeat of 'dire' commentary...that is what a competitor does...some are just, shall we say, more energetic and persistent. If Bioheart does, as I suspect they will, get MyoCell to market first, the battlefield may change, but our opposition will only intensify. That is because so very much is at stake..and why we must win!